Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000214287 | SCV000276472 | likely benign | Hereditary cancer-predisposing syndrome | 2019-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000214287 | SCV000913997 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-12-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001417887 | SCV001620095 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004590984 | SCV005083069 | likely benign | Familial cancer of breast | 2024-05-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |